6.
Sieghart W, Fuchs K, Tretter V, Ebert V, Jechlinger M, Hoger H
. Structure and subunit composition of GABA(A) receptors. Neurochem Int. 1999; 34(5):379-85.
DOI: 10.1016/s0197-0186(99)00045-5.
View
7.
Panieri E, Baralic K, Djukic-Cosic D, Djordjevic A, Saso L
. PFAS Molecules: A Major Concern for the Human Health and the Environment. Toxics. 2022; 10(2).
PMC: 8878656.
DOI: 10.3390/toxics10020044.
View
8.
Sigel E, Baur R, Trube G, Mohler H, Malherbe P
. The effect of subunit composition of rat brain GABAA receptors on channel function. Neuron. 1990; 5(5):703-11.
DOI: 10.1016/0896-6273(90)90224-4.
View
9.
Harada K, Ishii T, Takatsuka K, Koizumi A, Ohmori H
. Effects of perfluorooctane sulfonate on action potentials and currents in cultured rat cerebellar Purkinje cells. Biochem Biophys Res Commun. 2006; 351(1):240-5.
DOI: 10.1016/j.bbrc.2006.10.038.
View
10.
Cao Y, Ng C
. Absorption, distribution, and toxicity of per- and polyfluoroalkyl substances (PFAS) in the brain: a review. Environ Sci Process Impacts. 2021; 23(11):1623-1640.
DOI: 10.1039/d1em00228g.
View
11.
Rampersad S
. Multiple applications of Alamar Blue as an indicator of metabolic function and cellular health in cell viability bioassays. Sensors (Basel). 2012; 12(9):12347-60.
PMC: 3478843.
DOI: 10.3390/s120912347.
View
12.
Zhao L, Teng M, Zhao X, Li Y, Sun J, Zhao W
. Insight into the binding model of per- and polyfluoroalkyl substances to proteins and membranes. Environ Int. 2023; 175:107951.
DOI: 10.1016/j.envint.2023.107951.
View
13.
Naumann A, Alesio J, Poonia M, Bothun G
. PFAS fluidize synthetic and bacterial lipid monolayers based on hydrophobicity and lipid charge. J Environ Chem Eng. 2022; 10(2).
PMC: 9029377.
DOI: 10.1016/j.jece.2022.107351.
View
14.
Di Nisio A, Pannella M, Vogiatzis S, Sut S, DallAcqua S, Rocca M
. Impairment of human dopaminergic neurons at different developmental stages by perfluoro-octanoic acid (PFOA) and differential human brain areas accumulation of perfluoroalkyl chemicals. Environ Int. 2021; 158:106982.
DOI: 10.1016/j.envint.2021.106982.
View
15.
Olsen G, Burris J, Ehresman D, Froehlich J, Seacat A, Butenhoff J
. Half-life of serum elimination of perfluorooctanesulfonate,perfluorohexanesulfonate, and perfluorooctanoate in retired fluorochemical production workers. Environ Health Perspect. 2007; 115(9):1298-305.
PMC: 1964923.
DOI: 10.1289/ehp.10009.
View
16.
Chen L, Durkin K, Casida J
. Structural model for gamma-aminobutyric acid receptor noncompetitive antagonist binding: widely diverse structures fit the same site. Proc Natl Acad Sci U S A. 2006; 103(13):5185-90.
PMC: 1458815.
DOI: 10.1073/pnas.0600370103.
View
17.
Chen Z, Olsen R
. GABAA receptor associated proteins: a key factor regulating GABAA receptor function. J Neurochem. 2006; 100(2):279-94.
DOI: 10.1111/j.1471-4159.2006.04206.x.
View
18.
Emmett E, Shofer F, Zhang H, Freeman D, Desai C, Shaw L
. Community exposure to perfluorooctanoate: relationships between serum concentrations and exposure sources. J Occup Environ Med. 2006; 48(8):759-70.
PMC: 3038253.
DOI: 10.1097/01.jom.0000232486.07658.74.
View
19.
Yu Y, Wang C, Zhang X, Zhu J, Wang L, Ji M
. Perfluorooctane sulfonate disrupts the blood brain barrier through the crosstalk between endothelial cells and astrocytes in mice. Environ Pollut. 2019; 256:113429.
DOI: 10.1016/j.envpol.2019.113429.
View
20.
Liao C, Li X, Wu B, Duan S, Jiang G
. Acute enhancement of synaptic transmission and chronic inhibition of synaptogenesis induced by perfluorooctane sulfonate through mediation of voltage-dependent calcium channel. Environ Sci Technol. 2008; 42(14):5335-41.
DOI: 10.1021/es800018k.
View